Tag Archives: acute bacterial skin and skin-structure infections
FDA approves New Antibiotic for Pneumonia and Skin Infections
The US Food and Drug Administration (FDA) approves a new injectable antibiotic, ceftaroline fosamil (Teflaro; Forest Laboratories), for treating community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin-structure infections (ABSSSI), including the methicillin-resistant Staphylococcus aureus (MRSA). Ceftaroline is a … Continue reading
Posted in Others, Respiratory Disease
Tagged ABSSSI, acute bacterial skin and skin-structure infections, Antibiotic, CABP, ceftaroline fosamil, community-acquired bacterial pneumonia, methicillin-resistant Staphylococcus aureus, MRSA, Pneumonia, Skin Infections, Teflaro
Comments Off on FDA approves New Antibiotic for Pneumonia and Skin Infections